2018 Agenda


Monday, March 19, 2018

10:30 AM
REGISTRATION OPENS
11:30 AM
OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

Dr. Udit Batra, CEO, MilliporeSigma
David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit
Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute
Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health
Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

2:00 PM
WELCOME

Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

2:05 PM
SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT

The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.

The Fortune Brainstorm Health Co-Chairs:
Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health
Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health
Clifton Leaf, Fortune

2:20 PM
U.S. HEALTH CARE: AT THE CROSSROADS

A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.

Mark Bertolini, Chairman and CEO, Aetna Inc.

Interviewer: Clifton Leaf, Fortune

2:45 PM
MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM

Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.

Deborah DiSanzo, General Manager, IBM Watson Health
Amy Powell, President, Paramount Television and Digital Entertainment
Bernard J. Tyson, Chairman and CEO, Kaiser Permanente

Moderator: Arianna Huffington, Thrive Global

3:10 PM
THE BORDERLESS WORLD

If we’ve learned anything over past decades as we shape health care policy, it’s that the lines on the global map are thin and permeable, when they exist at all. From the spread of disease and emerging pathogens to the logistics of drug development and medical manufacturing, borders are increasingly irrelevant. We press some globally minded thinkers on how enterprises can manage the challenges of an increasingly connected planet—and better yet, tap the power of a connected world.

Joe Almeida, Chairman, President and CEO, Baxter International
George Barrett, Executive Chairman, Cardinal Health
Michael Milken, Chairman, Milken Institute

Moderator: Clifton Leaf, Fortune

3:35 PM
IN DEFENSE OF SCIENCE

We live in a time of mind-boggling change and technological advance. Cars drive themselves. Robots perform surgery. Phones can probe the connections of the universe. And humans edit the molecular instructions that shape their very humanity. Yet even as we hurtle through this futuristic present, swept up in discovery and innovation, a surprisingly powerful force is pushing back from the horizon: the fear of science. That force has rallied to challenge the foundation of science itself, undermining scientific research—and, yes, public health and safety. Now, more than ever, the field requires investment and talent, both of which are imperiled. How can we most effectively respond to this assault? What can be done to restore trust in science and fact? And how can we promote investment in science, and draw a new generation of enterprising thinkers to the field?

Dr. Susan Desmond-Hellmann, Chief Executive Officer, Bill & Melinda Gates Foundation
Dr. Margaret Hamburg, President, American Association for the Advancement of Science
Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine

Moderator: Dr. David B. Agus, University of Southern California

4:00 PM
BREAK
4:25 PM
IT’S NOT IMPOSSIBLE

What if nothing were impossible? That’s the rallying cry of this entrepreneur and filmmaker who takes his inspiration from turning tragedies and medical crises into technological breakthroughs. From printing 3D limbs for victims in war-torn Sudan to tackling Parkinson’s and bringing music to the deaf, Mick Ebeling brings new initiatives to technology for the sake of humanity. A shining example of how doing good is good business.

Mick Ebeling, Founder and CEO, Not Impossible Labs

4:35 PM
WHAT’S FOR SUPPER? BIG DATA AND THE FUTURE OF FOOD

While mass farming can feed millions of people, it has devastating consequences on the world’s water supply and the quality of food we eat. Enter SENSEI, a company that’s using precision data and hydroponic technology to farm with quantity, quality and sustainability in mind. Hear how the right technology can transform agriculture as we know it.

Daniel Gruneberg, President, SENSEI

4:40 PM
THE MOTHER OF INVENTION

Necessity isn’t the mother of invention, creativity is. But where do you find the special spark that can help transform a product from merely a “cool” piece of tech to a must-have that can change lives for the better? And, in an age when billions of dollars are being pumped into digital health and medical technology ventures, how can stakeholders identify the most promising innovations? A conversation with some of the most creative minds in the health space.

James Park, Co-founder and CEO, Fitbit
Dr. Martine Rothblatt, Chairman and Chief Executive Officer, United Therapeutics Corp.

Moderator: Sue Siegel, Chief Innovation Officer, GE; Chief Executive Officer, GE Ventures

5:05 PM
HELPING THE LEGALLY BLIND ACTUALLY SEE

How one company, eSight, is using breakthrough wearable technology to help the legally blind discover the world around them

Jeffrey Fenton, Director, Outreach and Communications, eSight

5:10 PM
PRECISION MEDICINE: WHERE IT’S WORKING AND WHY

The tools of molecular medicine, today, are homing in on human disease with a precision that could only be imagined a decade ago. New advances in big data, genomic medicine, and supercomputing are paving the way for targeted, personalized treatment. What has been the clinical impact so far—and what can we really expect in the five years to come? A deep dive with three individuals who are putting these tools into practice.

Kathy Giusti, Founder, Multiple Myeloma Research Foundation (MMRF); Faculty Co-chair, Kraft Precision Medicine Accelerator, Harvard Business School
Othman Laraki, Co-Founder and CEO, Color
Dr. Vijay Pande, General Partner, Andreessen Horowitz

Moderator: Dr. David B. Agus, University of Southern California

5:35 PM
THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

Dr. Jessica Mega, Chief Medical Officer, Verily
Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

6:00 PM
RECEPTION

Sunset Terrace

7:00 PM
FEATURED INTERVIEW

WELCOME
Deborah DiSanzo, General Manager, IBM Watson Health

THE SECRET TO TONY ROBBINS’ SUCCESS
He’s the go-to life and business strategist for high-octane CEOs, athletes, celebrities, and politicians. And, his empire of seminars, books, audio, video, and life training programs has empowered more than 50 million people from 100 countries who may not be lucky enough to have him on speed dial. Tony Robbins insists he can teach anyone to be confident, but where did the CEO Whisperer’s own strength come from? Fresh from another wildly popular “Unleash the Power Within” event, here’s Robbins as you’ve never seen him before. Joining us for an intimate interview in which he shares his own difficult personal upbringing, Robbins reveals how he went from homeless to household name—and how he can teach anyone else to believe in themselves.

Tony Robbins, Life and Business Strategist; Author, Unshakeable, Money: Master the Game

Interviewer: Dr. David B. Agus, University of Southern California

7:30 PM
DINNER

Dana Point Lawn

Hosted by IBM Watson Health

Tuesday, March 20, 2018

7:00 AM
EARLY MORNING MEDITATION

LOCATION: Environmental Center

Agapi Stassinopoulos, Author, Unbinding the Heart: A Dose of Greek Wisdom, Generosity, and Unconditional Love

7:45 AM
CONCURRENT BREAKFAST SOLUTION SESSIONS

WHY YOU SHOULD SLEEP THROUGH THIS SESSION
The data is real. A good night of sleep can have enormous benefits for our health, well-being, and productivity. Yet, despite the science, many of us continue to forgo the shut-eye we need. Part of the reason is a profound misunderstanding of productivity and where it comes from: While today’s digital world seems to demand that we’re always connected, there’s a smarter, healthier way to get more done. We explore what individuals and companies can do to create a well-rested workplace and what impact that can have on decision making, problem solving, and the bottom line. Can we really change the culture of ALWAYS ON? Rest assured, we can.

Liat Ben-Zur
, Senior Vice-President, Connected Digital Platforms and Propositions, Royal Philips
Roger Ekirch, Professor of History, Virginia Tech
Dr. Lauren Hale, Professor, Family, Population, and Preventive Medicine; Core Faculty, Program in Public Health, Stony Brook University School of Medicine
Cheri Mah, Research Fellow, Human Performance Center, UC San Francisco
Moderator: David Cloud, CEO, National Sleep Foundation

THE END OF HEALTH CARE PRIVACY… AND IS IT A GOOD THING?
Someone forgot to tell consumers to be careful. Over the past several years, people everywhere have zealously shared their intimate health data with products and services like 23AndMe, FitBit, and the Apple Watch—eager to be guinea pigs in the grand Big Data Experiment of Human Health. But when it comes to the broader medical universe, a matrix of rules and proprietary interests have made discovery from this deep data reservoir restrictive and challenging. Some, likewise, blame the frustrating lack of interoperability in health systems on a misreading of privacy protections—as well as on the unwillingness of private companies to play in the same data sandbox. How do we harness our limitless health-related data while still protecting individual privacy? And here’s a provocative question to start us off: Is privacy all it’s cracked up to be?

Anu Acharya, CEO, Mapmygenome
Dr. Kevin Ban, Chief Medical Officer, athenahealth
Colin Hill, Co-Founder, Chairman and CEO, GNS Healthcare
Chrissa McFarlane, Chief Executive Officer, Patientory
Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute
Hal Wolf, President and CEO, Healthcare Information and Management Systems Society
Moderator: Dr. David B. Agus, University of Southern California

WEAPONIZING YOUR OWN BODY
The newest tool in the medical arsenal is also the oldest: the human body itself. From patient blood cells modified to become cancer killers to molecules that release the reins on our internal Green Berets, the immune system may be modern medicine’s most effective commando force. But weaponizing the body doesn’t come cheap—with new drugs now listing in the high six figures and development costs running many times that amount. From CAR-Ts to souped-up stem cells to anticancer viruses, here’s what’s driving the wildest discovery engine in science—and what still stands in our way.

Dr. Anna Barker, Co-Director, Complex Adaptive Systems, Professor, School of Life Sciences, Arizona State University
Dr. Laurie Glimcher, President and CEO, Dana-Farber Cancer Institute
Dr. Thomas Lynch, Jr., Vice President, Chief Scientific Officer, Research and Development, Bristol-Myers Squibb
Dr. Jill O’Donnell-Tormey, Chief Executive Officer and Director of Scientific Affairs, Cancer Research Institute

Moderator: Clifton Leaf, Fortune

HOTTEST HEALTH CARE INVESTMENTS OF 2018
A record $5.8 billion poured into digital health care companies in 2017, and yet most signs suggest this revolution is just barely underway. Techniques for genome editing are in their infancy, so are personalized medicine and the data-driven tools that can help track and manage individual health. The meatier questions of the health system, meanwhile—policies around who gets care and how it gets paid for—remain uncertain. How do you invest in this rapidly changing landscape? Where’s the smart money headed now? And where should health and tech companies themselves place their next big wagers? A roundtable discussion.

Yumin Choi, Managing Director, Bain Capital Ventures
Jennifer Fonstad, Co-Founder, Aspect Ventures
Noah Knauf, General Partner, Kleiner Perkins
Ian Sigalow, Co-Founder and Partner, Greycroft
David Singer, Managing Partner, Maverick Ventures

Moderator: Michal Lev-Ram, Fortune

8:45 AM
SWITCH BREAK
9:05 AM
THE NEXT ENDANGERED SPECIES: THE DOCTOR

Lost in the conversation of the digital health revolution is the focus on humans that often drive transformation in healthcare and that’s the medical doctor. We’ve seen doctors increasingly demoralized, depressed, and under pressure to meet mounting administrative loads while maintaining impeccable, patient-rated “healthgrades” online. The epidemic of burnout now affects almost two-thirds of America’s physicians according to a recent Medscape study. They’re frustrated by the payment systems and being pushed out by large health systems that imagine others doing their work and stripping them of authority. They spend less and less time with patients, and there’s giddy talk about how soon robots—already active in surgery and radiology—will do it all. Do we really want to imagine a world without doctors?

Dr. Toby Cosgrove, Former President and CEO, Cleveland Clinic
Dr. Laurie Glimcher, President and CEO, Dana-Farber Cancer Institute

Moderator: Dr. David B. Agus, University of Southern California

9:30 AM
THE POWER OF BEDSIDE DATA

A technology that monitors a person’s respiratory rate, heart rate and movement may not seem, at first, like much of an innovation—but consider that EarlySense does this by way of a sensor slipped under your mattress. That allows staff at anywhere from hospitals to nursing homes keep an electronic eye on non-critical patients’ vital signs—in a way that doesn’t have to be invasive. Princess and the Pea: Meet the digital age.

Dr. Karissa Price-Rico, COO, EarlySense Ltd.

9:35 AM
CAN A MACHINE STAFF YOUR HOSPITAL?

It has been called the great mismatch: legions of applicants for today’s 21st-century jobs aren’t prepared for the many positions available; meanwhile tens of thousands of talented people aren’t getting to put their skills to use—and the challenge is particularly acute in the health care economy. Meet the founder of one startup who believes she has the solution: using machine learning to find people with the traits most likely to make them great performers.

Kristen Hamilton, CEO and Co-founder, Koru

9:40 AM
HOW AI WILL CHANGE MEDICINE

The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.

Adrian Aoun, CEO and Founder, Forward
Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health
Julie Sweet, Chief Executive Officer, North America, Accenture

Moderator: Clifton Leaf, Fortune

10:05 AM
WHO’S THE BOSS?

In the digital health revolution, the patient is supposed to be king. But in a world where this consumer doesn’t pay for much of his or her care, isn’t confident about his or her knowledge of the marketplace, and doesn’t have that much choice anyway, can he or she really be in charge? (If the answer is no, how do we change this paradigm?)

Dr. Valerie Montgomery Rice, President and Dean, Morehouse School of Medicine
Christi Shaw, President, Lilly Bio-Medicines
Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute

Moderator: Beth Kowitt, Senior Writer and Co-chair, MPW Next Gen, Fortune

10:30 AM
MEDITATION: GETTING INTO YOUR HEADSPACE

Andy Puddicombe, Co-Founder, Headspace

10:45 AM
CLIMBING OUT OF LAST PLACE: WEST VIRGINIA AND WELL-BEING

West Virginia consistently ranks last out of the 50 U.S. states when it comes to well-being—with the state levels of obesity, poverty, unemployment, and opioid abuse at or near the worst in the nation. But a surprising ray of hope is on the horizon—a new clinical program designed to help the Mountain State address these issues in a radical way. We offer an early look.

Dr. E. Gordon Gee, President, West Virginia University
Dr. Clay Marsh, Vice President and Executive Dean for Health Sciences, West Virginia University
Dr. Ali Rezai, Executive Chair, Vice President and Associate Dean, WVU Rockefeller Neuroscience Institute

Moderator:
Arianna Huffington, Thrive Global

11:10 AM
A MOTHER FIGHTS BACK: USING BIG DATA AND GENOMICS TO SILENCE HER SON’S KILLER

Theresa Beech’s 13-year-old son Daniel died nearly two years ago from osteosarcoma. Daniel’s killer: a pediatric bone cancer whose treatment—and survival rates—haven’t changed in 30 years. But the time for change is now. Driven by the hope that she can spare other families this same pain and loss, Theresa — a NASA space engineer by day— has collected more than 130 genetic codes from young patients whose parents donated the data. What she has discovered offers hope for progress at last. The unbelievable story of one woman’s race to cure a terrible cancer.

Theresa Beech, President, Because of Daniel

11:20 AM
BREAK
11:45 AM
WHY YOUR TEENAGER ISN’T CRAZY…REALLY.

Parents of teens: We may finally have the answer you’ve been looking for. A leading neuroscientist and author of The Teenage Brain explains how brain development is at least partly to blame for your moody and impulsive kids (and their, at times, notoriously subpar decision-making skills). Her research also pulls back the curtain on the effects of multitasking and why addiction—to drugs and technology—is especially dangerous during these critical years.

Dr. Frances Jensen, Professor of Neurology, Perelman School of Medicine, University of Pennsylvania

12:00 PM
THE SMARTPHONE-ACID DOPAMINE-DRIVEN FEEDBACK LOOPS

Why you’re an addict and you don’t even know it: A 21st century dilemma.

Tristan Harris, Co-founder, Time Well Spent

12:10 PM
FROM CLOUD HOSPITALS TO HUMAN CELL PRINTING: HOW CHINA IS LEADING THE WAY

Chinese entrepreneurs and leaders are racing to develop health care solutions that can better serve the country’s 1.3 billion people—and much of the inspiration for these innovations is home-grown. As China takes leaps forward in digital connectivity, big data analytics, 3D printing, and artificial intelligence, other nations—including some industrial giants—are suddenly finding themselves in the slow lane, held back by budget cuts, red tape, and entrenched systems. Some insights from one health care pioneer on what it will take to stay competitive in the global race to innovate.

Dr. Jiren Liu, Chairman and CEO, Neusoft Corporation

Interviewer: Dr. David B. Agus, University of Southern California

12:30 PM
HOW TO CHANGE THE COURSE OF A DISEASE

It’s the last frontier: the human brain. When it comes to medical treatment, the brain and central nervous system remain the darkest, most forbidding, realm—even as our knowledge of how the brain and mind work grows by leaps each year. Now, some say we are at the edge of genuine breakthroughs in treatment for diseases that have haunted humankind for generations, from Huntington’s to ALS to Alzheimer’s. Two warriors on the front lines of brain science will share the latest discoveries and discuss what it will take to solve the most complex puzzles of our most complex organ.

Ann Romney, Global Ambassador, Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital
Dr. Rudolph Tanzi, Vice Chair of Neurology and Director, Genetics and Aging Research Unit, Massachusetts General Hospital; Professor of Neurology, Harvard Medical School

Moderator: Arianna Huffington, Thrive Global

12:45 PM
SWITCH BREAK
1:00 PM
CONCURRENT LUNCH SOLUTION SESSIONS

HEALTH CARE AND THE FOURTH INDUSTRIAL REVOLUTION
Hosted by Herman Miller
The industrial revolutions of yore heralded a transition from hand-powered production methods to machine-driven ones and the advent of mass production. The next industrial revolution is a decidedly digital one—and its implications for health care may be more significant than for any other industry. Far beyond telemedicine, the digital age isn’t just changing how we do medicine, but also how we define it. From the health gig economy to AI-run hospitals to on-demand diagnostics, technology is prompting a never-ending question: Where will this fourth revolution take us next?
Hema Budaraju, Product Lead, Health, Facebook
Sally Daub, CEO, Enlitic
Sajid Rahman, CEO, Telenor Health
Dr. Roy Schoenberg, President and CEO, American Well
Owen Tripp, Co-Founder and CEO, Grand Rounds
Moderator: Dr. David B. Agus, University of Southern California
Introduction: Mike O’Toole, Senior Vice President of Sales, Herman Miller

PATIENT TRIALS WE CAN ACTUALLY LEARN FROM
Hosted by City of Hope
The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health
Matt de Silva, Co-Founder, CEO and Director, Notable Labs
Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator
Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation
Moderator: Clifton Leaf, Fortune

MEDICAL INGENUITY — AT HALF THE PRICE
Hosted by Abbott
One thing we are very good at: creating medical marvels. Not so good at: making them affordable. So how do you squeeze more value out of innovation? One answer is to bring affordability into the ideation and design process from the very beginning. A conversation that probes the least explored part of ingenuity: patient value.

Jeffrey Brewer, Co-founder, President and CEO,, Bigfoot Biomedical
Dr. Toby Cosgrove, Former President and CEO, Cleveland Clinic
Dr. Jiren Liu, Founder, Chairman, and CEO, Neusoft Corp.
Katherine Steinberg, Vice President, Center for Healthcare Transformation, Avalere Health
Jared Watkin, Senior Vice President, Diabetes Care, Abbott
Moderator: Michal Lev-Ram, Fortune

2:15 PM
BREAK
2:25 PM
GUN VIOLENCE AS A PUBLIC HEALTH CRISIS

American students were once again caught in the crosshairs of a school massacre on Valentine’s Day—just after the country witnessed two of its deadliest mass shootings in a 35-day span. Parkland. Las Vegas. Sunderland. Newtown. The painful reminders that the U.S. is the world capital of gun violence keep piling up. Compounding this continuing sorrow is a bitter feud over how to stop it—a fight over firearms that has further polarized the nation. But some health experts say there’s a way to break through this deadly impasse: What if, instead of isolated acts of madness, we treated the ongoing casualties from guns as an epidemic? Here’s how reframing gun violence as an urgent matter of public health might at last lead us to a cure.

Nza-Ari Khepra, Co-Founder, Project Orange Tree; Co-Creator, Wear Orange Campaign
Dr. Dean Winslow, Professor of Medicine, Stanford University School of Medicine
Dr. Garen Wintemute, Director, Violence Prevention Research Program, UC Davis
Moderator: Michal Lev-Ram, Fortune

2:55 PM
FOLLOW THE GAZE: WHAT WEBCAM EYE-TRACKING CAN TEACH US

Our eyes and the way we look at our screens have the potential to unlock crucial data that can transform the way we are treated. A demonstration of one of the most eye-opening new diagnostic technologies coming down the pike.

Dr. Alexandra Papoutsaki, Assistant Professor in Computer Science, Pomona College

3:05 PM
SEEING AROUND THE CORNER: THE SEARCH FOR A UNIVERSAL FLU VACCINE

This year marks not only a particularly brutal flu season in the U.S., but also the 100th anniversary of the 1918 Spanish Flu. That historic pandemic infected 500 million people, killing 50 million — or five percent of the world’s population. With hundreds of thousands of people still dying annually from the seasonal flu, how long before a universal flu vaccine is a reality? We’ll hear from one leader working feverishly to make sure we’re protected next time a killer bug hits home.

Dr. Bruce Gellin, President, Global Immunization, Sabin Vaccine Institute

3:15 PM
BREAK
3:35 PM
WHY DON’T WE TALK ABOUT DEATH?

Consider this: 70 percent of Americans want to die at home. Only 30 percent do. And yet we spend an awful lot of money giving people an end of life they don’t want: Medicare, for instance, spends nearly 30 percent of its annual outlays on individuals in the last year of their lives. Meanwhile, caregivers shoulder an enormous burden as they help loved ones in their final months and years. How did we end up here? One reason: we don’t talk about it. Well, guess what: we’re about to start.

Alexandra Drane, Co-founder, ARCHANGELS; Co-founder, Eliza Corporation
Michael Hebb, Founder, Death over Dinner
Venerable Tenzin Priyadarshi, Director, Ethics Initiative, MIT Media Lab

Moderator: Arianna Huffington, Thrive Global

4:05 PM
TAKE TWO TERABYTES AND CALL ME IN THE MORNING: DATA’S GROWING ROLE IN THE MEDICAL TOOL BOX

At the core of precision medicine is precision: the critical need to hit, square on, a moving target in a body chock full of moving targets. To keep the aim sound, we need more than a steady hand, we need data. Smart data, and lots of it. That imperative has driven much of the innovation—and investment—in the current digital health transformation. Entrepreneurs and corporate leaders are now championing the role of big data in everything from drug development to predictive analytics in cancer diagnosis to hospital systems management—and putting billions of dollars behind these efforts. Do the numbers add up, or is the promise of big data yet another false medical miracle?

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health
Dr. Anil Jain, Vice President and Chief Health Information Officer, IBM Watson Health
Dr. Mona Siddiqui, Chief Data Officer, U.S. Dept. of Health and Human Services

Moderator: Clifton Leaf, Fortune

4:30 PM
A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

An intimate conversation with Kevin Durant, who led the 2017 Golden State Warriors to an NBA Championship and was named MVP in the process. The eight-time NBA-All Star and two-time Olympic gold medalist continues to shatter records, while growing his base of passionate basketball fans in Silicon Valley — and around the country. Durant shares with Thrive Global’s Arianna Huffington what it takes to stay fit and focused on the court, how he prioritizes recovery before a big game, and how health and well-being fit into his grueling schedule. What role does tech play in sports and fitness and how can it help the world’s top athletes achieve maximum performance? Joining Durant, his business partner and manager Rich Kleiman will discuss investing and their growing tech and media empire, and how he preps himself for success. A probing conversation about the connection between well-being and performance, and Durant and Kleiman’s latest work in investment, entrepreneurship and philanthropy.

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors
Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

Moderator:Arianna Huffington, Thrive Global

5:00 PM
CLOSING RECEPTION